Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

scientific article

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/01.AIDS.0000238407.00874.DC
P698PubMed publication ID16868442

P50authorHarvey M. FriedmanQ89912954
Gregory P BissonQ91276180
Jordan B StromQ91986877
Scarlett BellamyQ102312298
P2093author name stringBrian L Strom
Ian Frank
Ndwapi Ndwapi
Tendani Gaolathe
Robert Gross
Diana Dickinson
Jordan B Strom
Rachel Weinstein
Caitlin Rollins
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectvirologyQ7215
anti-retroviral agentQ50430310
P1104number of pages7
P304page(s)1613-1619
P577publication date2006-08-01
P1433published inAIDSQ4651863
P1476titleDiagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy
P478volume20

Reverse relations

cites work (P2860)
Q34464667A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings--experience from Lesotho.
Q44265409A model for reduced HIV-1 viral load monitoring in resource-limited settings
Q64280420A prospective study to evaluate efficacy of second-line antiretroviral therapy given to human immunodeficiency virus patients at Antiretroviral Therapy Plus Centre in India
Q37043399Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy
Q36793821Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults.
Q34814795Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy
Q37325907CD4+ response and subsequent risk of death among patients on antiretroviral therapy in Lusaka, Zambia
Q46643116Can the initial success of the Malawi ART scale-up programme be sustained? The example of Queen Elizabeth Central Hospital, Blantyre
Q42204657Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32-35 weeks' gestational age with more informed use of risk factors?
Q37955946Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less
Q37025655Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa
Q28730357Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe
Q37147686Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria
Q36576089Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda
Q37165025Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures -- a meta-analysis.
Q37149013Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy
Q37288419Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda
Q84420336Five-year outcomes of the China National Free Antiretroviral Treatment Program
Q34735495HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City
Q34731031Long-Term Outcome of an HIV-Treatment Programme in Rural Africa: Viral Suppression despite Early Mortality
Q81161975Monitoring antiretroviral failure in resource-poor settings
Q33497943Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay
Q33862806Mortality after failure of antiretroviral therapy in sub-Saharan Africa
Q37405560Novel pH sensing semiconductor for point-of-care detection of HIV-1 viremia
Q37658177Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure
Q28472810Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
Q34042986Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection.
Q34518252Prediction based classification for longitudinal biomarkers
Q33751459Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana
Q36083869Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa
Q53086924State of the ART: clinical efficacy and improved quality of life in the public antiretroviral therapy program, Free State province, South Africa.
Q37602847Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries
Q36090721Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy
Q35099443Systematic review of the performance of HIV viral load technologies on plasma samples
Q34049901The efficacy of a computerized assessment of medication adherence in active substance users
Q41693941Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam
Q33349204Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting
Q35541563Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial
Q33622913Who is accessing public-sector anti-retroviral treatment in the Free State, South Africa? An exploratory study of the first three years of programme implementation

Search more.